Begin main content

Reports

We found 5104 result(s)

letermovir (Prevymis)

Last Updated: June 22, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: letermovir
Indications: Cytomegalovirus infection, prophylaxis

  • Brand Name: Prevymis
  • Manufacturer: Merck Canada Inc.
  • Project Number: SR0545-000
  • Project Status: Active
  • Submission Type: New

Tags

Infectious Diseases, Cystinosis, Delayed-Action Preparations, HIV/AIDS, Infectious diseases, cysteamine bitartrate; Procysbi; nephropathic; cystinosis; extended release; delayed action; delayed release; controlled release; Long acting; time release

fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta)

Last Updated: June 22, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: fluticasone furoate umeclidinium vilanterol
Indications: Chronic obstructive pulmonary disease (COPD)

  • Brand Name: Trelegy Ellipta
  • Manufacturer: GlaxoSmithKline Inc.
  • Project Number: SR0562-000
  • Project Status: Active
  • Submission Type: NewCombination

Tags

COPD, COPD, Respiratory

rivaroxaban (Xarelto)

Last Updated: June 22, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: rivaroxaban
Indications: Prevention of stroke and cardiovascular events in coronary and peripheral artery disease.

  • Brand Name: Xarelto
  • Manufacturer: Bayer Inc.
  • Project Number: SR0569-000
  • Project Status: Active
  • Submission Type: NewIndication

Tags

Coronary Artery Disease, Stroke, Cardiovascular, Coronary artery disease, Heart attack, Peripheral vascular disease, Stroke

lixisenatide + insulin glargine (Soliqua)

Last Updated: June 22, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: lixisenatide + insulin glargine
Indications: Diabetes mellitus, Type 2

  • Brand Name: Soliqua
  • Manufacturer: sanofi-aventis Canada Inc.
  • Project Number: SR0564-000
  • Project Status: Active
  • Submission Type: NewCombination

Tags

Diabetes Mellitus, Diabetes, Diabetes; Diabetic; soliqua; suliqua; iglarlixi; Lantus; glargine; lixisenatide; Lyxumia

Dolutegravir / rilpivirine (Juluca)

Last Updated: June 22, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: Dolutegravir rilpivirine
Indications: HIV infection

  • Brand Name: Juluca
  • Manufacturer: ViiV Healthcare ULC
  • Project Number: SR0551-000
  • Project Status: Complete
  • Submission Type: NewCombination

Tags

Infectious Diseases, HIV, Human Immunodeficiency Virus Proteins, HIV/AIDS, Infectious diseases, HIV; rilpivirine; dolutegravir; Juluca; human immuno-deficiency virus; Human immunodeficiency virus; human immuno-deficiency viruses; human immunodeficiency viruses

netupitant / palonosetron (Akynzeo)

Last Updated: June 22, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: netupitant / palonosetron
Indications: Nausea and vomiting (chemotherapy induced) prevention

  • Brand Name: Akynzeo
  • Manufacturer: Purdue Pharma
  • Project Number: SR0548-000
  • Project Status: Complete
  • Submission Type: NewCombination

Tags

Cancer, Digestive System, Cancer, Digestive system, Antiemetic; antiemetics; Nausea; Vomiting; Cancer; Neoplasm; palonosetron; netupitant; Akynzeo

nitisinone (Nitisinone )

Last Updated: June 21, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: nitisinone
Indications: Hereditary tyrosinemia type 1

  • Brand Name: Nitisinone
  • Manufacturer: Cycle Pharmaceuticals Ltd.
  • Project Number: SR0554-000
  • Project Status: Active
  • Submission Type: New

Tags

Genetics, Pediatrics, Genetics, Pediatrics

brodalumab (Siliq)

Last Updated: June 22, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: brodalumab
Indications: Psoriasis, moderate to severe plaque

  • Brand Name: Siliq
  • Manufacturer: Valeant Canada LP
  • Project Number: SR0547-000
  • Project Status: Active
  • Submission Type: New

Tags

Dermatology, Psoriasis, Dermatology, brodalumab; siliq; psoriases; psoriatic

cladribine (Mavenclad)

Last Updated: June 20, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: cladribine
Indications: Multiple Sclerosis, relapsing

  • Brand Name: Mavenclad
  • Manufacturer: EMD Serono, a Division of EMD Inc., Canada
  • Project Number: SR0546-000
  • Project Status: Active
  • Submission Type: New

Tags

Multiple Sclerosis, Nervous System, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Multiple sclerosis, Nervous system, Multiple sclerosis, cladribine; RRMS

Recommendations Framework for Drugs for Rare Diseases: A Review of Health Technology Assessment Agencies

Published on: June 22, 2018
Result type: Reports
Product Line: Environmental Scans

The drug for rare diseases (DRD) pipeline with the number of marketed DRDs is expanding. As such, policy-makers and clinicians have struggled on how to make these drugs that are associated with potentially significant cost, available to patients while ensuring that only clinical- and cost-effective treatments are reimbursed. This Environmental S...

  • Project Number: ES0326-000

Tags

Comparative Effectiveness Research, Drug Approval, Formularies as Topic, Orphan Drug Production, Rare Diseases, Technology Assessment, Other miscellaneous topics, Biomedical, Health technology assessments, Orphan drugs, formularies; Evaluation, reimbursement